Stephen Lin
Private Equity Investor at LAV Management Co., Ltd.
Profile
Stephen Lin, is a Partner with Lilly Asia Ventures (LAV).
Prior to joining LAV, he most recently worked as BD at GlaxoSmithKline (Great China), covering M&A and product licensing.
Prior to that, he managed the marketing of a core product at Merck Serono (China).
In Sanjiu Medical & Pharmaceutical, he set up and headed the Strategic Development Department.
Stephen holds Master of Science in Medicinal Chemistry and Bachelor in Pharmaceutical Chemistry, both from China Pharmaceutical University, and an M.B.A.
degree from China Europe International Business School.
He is also a Licensed Pharmacist in China.
Stephen Lin active positions
Companies | Position | Start |
---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | - |
GlaxoSmithKline Biologicals (Shenzhen) Co., Ltd. | Corporate Officer/Principal | - |
Training of Stephen Lin
China Europe International Business School | Masters Business Admin |
China Pharmaceutical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
GlaxoSmithKline Biologicals (Shenzhen) Co., Ltd. |
- Stock Market
- Insiders
- Stephen Lin